Dr. Reddy's Laboratories (EU) Ltd. Steanard Lane
FDA inspection history in Mirfield, United Kingdom, 2025
- 2
- Form 483s
Every document, by year
- Form 483
2025: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2025One Form 483, at Mirfield, United Kingdom.
- 2025The longest 483 on file: 2 observations over 7 pages at Mirfield, United Kingdom.
Cited most
Across all Dr. Reddy's Laboratories (EU) Ltd. Steanard Lane observations on file
- 21 CFR 211.160General requirements1
- 21 CFR 211.22Responsibilities of quality control unit1
- 21 CFR 211.84Testing and approval or rejection of components, drug product containers, and closures1
The complete Dr. Reddy's Laboratories (EU) Ltd. Steanard Lane file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Mirfield, United Kingdom
Two Form 483s · 2025 · 3 observations
Latest: Form 483, Sep 5, 2025 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2025-09-05 | 483 Form 483 | Mirfield, United Kingdom | 2 | $99 |
| Undated | 483 Form 483 | Mirfield, United Kingdom | 1 | $99 |
Investigators on these documents
FEI number 3002807544 · most recent document Sep 5, 2025
About Dr. Reddy's Laboratories (EU) Ltd. Steanard Lane
How many FDA Form 483s has Dr. Reddy's Laboratories (EU) Ltd. Steanard Lane received?
FDA Intel has 2 Form 483s on file for Dr. Reddy's Laboratories (EU) Ltd. Steanard Lane; the most recent is dated Sep 5, 2025.
When was Dr. Reddy's Laboratories (EU) Ltd. Steanard Lane last inspected by FDA?
The most recent FDA inspection document on file for Dr. Reddy's Laboratories (EU) Ltd. Steanard Lane is a Form 483 dated Sep 5, 2025, for the site in Mirfield, United Kingdom.
What did FDA cite at Dr. Reddy's Laboratories (EU) Ltd. Steanard Lane?
The regulations cited most in the observations on file for Dr. Reddy's Laboratories (EU) Ltd. Steanard Lane are 21 CFR 211.160 (General requirements), 1 time; 21 CFR 211.22 (Responsibilities of quality control unit), 1 time; 21 CFR 211.84 (Testing and approval or rejection of components, drug product containers, and closures), 1 time.